Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00303472
Status:
COMPLETED
Last Update Posted:
2013-12-16
First Post:
2006-03-16
Brief Title:
Determination of Safe Dose of Romiplostim AMG 531 in Patients With Myelodysplastic Syndromes MDS
Sponsor:
Amgen
Organization:
Amgen